Catherine Simpson
Affiliations: | 2015- | Chemistry | Australian National University, Acton, Australian Capital Territory, Australia |
Google:
"Catherine Simpson"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Simpson CE, Ambade AS, Harlan R, et al. (2023) Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology. 325: L617-L627 |
Simpson CE, Ambade AS, Harlan R, et al. (2023) Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension. Pulmonary Circulation. 13: e12260 |
Simpson CE, Hemnes AR, Griffiths M, et al. (2023) Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort. Arthritis & Rheumatology (Hoboken, N.J.) |
Philip N, Pi H, Gadkari M, et al. (2023) Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension. Pulmonary Circulation. 13: e12205 |
Naranjo M, Mercurio V, Hassan H, et al. (2022) Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension. Erj Open Research. 8 |
Simpson CE, Kolb TM, Hsu S, et al. (2022) Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension. Pulmonary Circulation. 12: e12005 |
Daly CM, Griffiths M, Simpson CE, et al. (2021) Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension. Journal of the American Heart Association. e021409 |
Griffiths M, Yang J, Simpson CE, et al. (2021) ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening. Chest |
Chen JY, Griffiths M, Yang J, et al. (2020) Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. The Journal of Pediatrics. 223: 164-169.e1 |
Simpson CE, Damico RL, Hassoun PM, et al. (2020) Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension. Chest |